Predictions
Idexx Laboratories Inc.
Start price
Target price
Perf. (%)
€481.30
14.05.24
14.05.24
€550.70
14.05.25
14.05.25
1.48%
20.05.24
20.05.24
Idexx Laboratories Inc.
Start price
Target price
Perf. (%)
€481.30
14.05.24
14.05.24
€550.70
14.05.25
14.05.25
1.48%
20.05.24
20.05.24
Idexx Laboratories Inc.
Start price
Target price
Perf. (%)
€481.30
14.05.24
14.05.24
€550.70
14.05.25
14.05.25
1.48%
20.05.24
20.05.24
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.67
14.05.24
14.05.24
€4.62
14.05.25
14.05.25
9.73%
16.05.24
16.05.24
Edwards Lifesciences Corp.
Start price
Target price
Perf. (%)
€79.28
14.05.24
14.05.24
-
14.05.25
14.05.25
3.90%
20.05.24
20.05.24
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€128.25
14.05.24
14.05.24
€161.95
14.05.25
14.05.25
1.44%
20.05.24
20.05.24
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€909.80
14.05.24
14.05.24
€1,064.2
14.05.25
14.05.25
-0.57%
20.05.24
20.05.24
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€909.80
14.05.24
14.05.24
€1,064.2
14.05.25
14.05.25
-0.57%
20.05.24
20.05.24
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€909.80
14.05.24
14.05.24
€1,064.2
14.05.25
14.05.25
-0.57%
20.05.24
20.05.24
Novavax Inc.
Start price
Target price
Perf. (%)
€12.15
13.05.24
13.05.24
-
13.05.25
13.05.25
9.89%
08:48
08:48
Top 10 in its market
Could be worthwhile Investment >10% per year
Leading role in innovation
Very Future proof/growth oriented business model
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€20.12
13.05.24
13.05.24
€83.32
13.05.25
13.05.25
14.41%
16.05.24
16.05.24
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€11.00
13.05.24
13.05.24
€27.78
13.05.25
13.05.25
-1.09%
17.05.24
17.05.24
Biogen Inc.
Start price
Target price
Perf. (%)
€205.20
12.05.24
12.05.24
€207.00
12.05.25
12.05.25
3.90%
20.05.24
20.05.24
Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio
Biogen Inc.
Start price
Target price
Perf. (%)
€205.20
12.05.24
12.05.24
€207.00
12.05.25
12.05.25
3.90%
20.05.24
20.05.24
Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio
Biogen Inc.
Start price
Target price
Perf. (%)
€205.20
12.05.24
12.05.24
€207.00
12.05.25
12.05.25
3.90%
20.05.24
20.05.24
Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€4.15
11.05.24
11.05.24
-
11.05.25
11.05.25
-13.40%
20.05.24
20.05.24